Ignite Creation Date:
2025-12-24 @ 5:20 PM
Ignite Modification Date:
2026-01-24 @ 2:36 PM
Study NCT ID:
NCT05708950
Status:
UNKNOWN
Last Update Posted:
2023-07-13
First Post:
2022-12-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Sponsor:
Kineta Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cancer | View |
| None | Solid Tumor | View |
| None | Melanoma | View |
| None | Carcinoma | View |
| None | Sarcoma | View |
| None | Lung Cancer | View |
| None | Prostate Cancer | View |
| None | Breast Cancer | View |
| None | Colo-rectal Cancer | View |
| None | Uterine Cancer | View |
| None | Pancreatic Cancer | View |
| None | Gastric Cancer | View |
| None | Esophageal Cancer | View |
| None | Thyroid Cancer | View |
| None | Ovarian Cancer | View |
| None | Kidney Cancer | View |
| None | Head and Neck Cancer | View |
Keywords: